Work

Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies

Year: 2007

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

Authors: David S. Hong, Razelle Kurzrock, Jeffrey G. Supko, Donald P. Lawrence, Jennifer Wheeler, Joseph P. Eder, Chaan Ng, James W. Mier, Marina Konopleva, Sergej Konoplev, Sühendan Ekmekçioglu, Michael Andreeff, Elizabeth Grimm, Donald Küfe, Colin J. Meyer, Geoffrey I. Shapiro, Bruce J. Dezube

Institution: Beth Israel Deaconess Medical Center

Language: English

Topic: Natural product bioactivities and synthesis

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W796471661

FWCI: 0.527

Cites:

Cited by: 5

Related to: 10